Literature DB >> 2907543

A rapid and sensitive high-performance liquid chromatographic method for the determination of diclofenac sodium in serum and its use in pharmacokinetic studies.

Y M el-Sayed1, M E Abdel-Hameed, M S Suleiman, N M Najib.   

Abstract

A rapid, and sensitive high-performance liquid chromatographic method has been developed for the determination of diclofenac sodium in serum using flufenamic acid as the internal standard. Serum protein was precipitated with acetonitrile. The drugs were eluted from a 5 microns C-8 reversed-phase column at ambient temperature with a mobile phase consisting of acetonitrile-water (50:50% v/v) adjusted to pH 3.3 with glacial acetic acid, at a flow rate of 2 mL min-1 with UV detection at 280 nm. Each analysis required no longer than 10 min. Quantitation was achieved by the measurement of the peak-height ratio and the relative and absolute recoveries varied from 90 to 98%. Detection limits for diclofenac sodium in serum is 25 ng mL-1. Intraday coefficients of variation (CV) ranged from 2.47 to 4.61% and interday CVs from 3.52 to 7% at three different concentrations. Preliminary stability tests showed that diclofenac sodium is stable for at least 2 weeks in serum after freezing. The method is applied for the determination of the pharmacokinetic parameters of diclofenac after administration of two formulations (enteric-coated tablet and slow-release tablet), to a healthy male volunteer.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2907543     DOI: 10.1111/j.2042-7158.1988.tb07005.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  9 in total

Review 1.  Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls.

Authors:  N M Davies; K E Anderson
Journal:  Clin Pharmacokinet       Date:  1997-09       Impact factor: 6.447

2.  Population pharmacokinetics of fast release oral diclofenac in healthy volunteers: relation to pharmacodynamics in an experimental pain model.

Authors:  J Lötsch; B Kettenmann; B Renner; D Drover; K Brune; G Geisslinger; G Kobal
Journal:  Pharm Res       Date:  2000-01       Impact factor: 4.200

3.  Diclofenac metabolic profile following in vitro percutaneous absorption through viable human skin.

Authors:  H Tanojo; R C Wester; J Z Shainhouse; H I Maibach
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Oct-Dec       Impact factor: 2.441

4.  Possible mechanism by which the carbapenem antibiotic panipenem decreases the concentration of valproic acid in plasma in rats.

Authors:  S Kojima; M Nadai; K Kitaichi; L Wang; T Nabeshima; T Hasegawa
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

5.  Evaluation of intestinal absorption into the portal system in enterohepatic circulation by measuring the difference in portal-venous blood concentrations of diclofenac.

Authors:  K Tabata; K Yamaoka; T Fukuyama; T Nakagawa
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

6.  Effect of itraconazole on the pharmacokinetics of diclofenac in beagle dogs.

Authors:  Fahad I Al-Jenoobi
Journal:  Sci Pharm       Date:  2010-05-19

7.  Oral pharmacokinetics of the acidic drugs, diclofenac and sulfamonomethoxine in male Shiba goats.

Authors:  Mohamed Elbadawy; Takara Sakiyama; Rania Abohatab; Kazuaki Sasaki; Minoru Shimoda
Journal:  J Vet Med Sci       Date:  2014-10-10       Impact factor: 1.267

8.  Square Wave Voltammetric Determination of Diclofenac in Pharmaceutical Preparations and Human Serum.

Authors:  Ulvihan Ciltas; Bilal Yilmaz; Selcuk Kaban; Bilge Kaan Akcay; Gulsah Nazik
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

9.  Determination of diclofenac concentrations in human plasma using a sensitive gas chromatography mass spectrometry method.

Authors:  Iltaf Shah; James Barker; Declan P Naughton; Stephen J Barton; Syed Salman Ashraf
Journal:  Chem Cent J       Date:  2016-08-17       Impact factor: 4.215

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.